Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

kbiosystems Ltd UK Custom Project Division See Sharp Increase in Business

Published: Thursday, January 02, 2014
Last Updated: Thursday, January 02, 2014
Bookmark and Share
Company has seen an increase in the number of custom automation projects globally with the added benefit of entering in to new market sectors.

John Woodford, Director of kbiosystems Ltd, who is spearheading the changes, commented “Over the last few years our business has grown and the markets we now serve have. We continue to provide standard products for the Life Sciences industry with some exciting new products due for launch in 2014, our custom project division are working in differing industries to those we did in the past. These industries include Biofuels, Diagnostics and the Optical Lens production, third party OEM and full production automation both large and small”.

Although the projects worked on have all been under non-disclosure agreements, the diversity of requirements highlights the expertise kbiosystems Ltd have in house to adapt to the ever changing needs of the clients.

John Woodford, who heads up this division and part owner of kbiosystems Ltd says “Our key strength is the ability to take a concept from our clients and provide them with a detailed plan of the end product designed from our own design department. With a manufacturing workshop, having recently had a £250,000 investment, we are able to provide our clients with a solution that exceeds their expectations”. He adds “We pride ourselves on designing and engineering solutions that are robust and stand the test of time. Many products are still working from our early days. The after sales care is second to none and believe in building long lasting relationships with customers that culminates in repeat and referred business”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!